Perkin Elmer GeneAmp 9700 PCR

One Bench at a Time

Perkin Elmer GeneAmp 9700 PCR

The Perkin Elmer GeneAmp 9700 PCR Thermo Cycler system is intended to be used for high-sample-volume polymerase chain reaction (PCR) applications including DNA and RNA. Users can take advantage of oil-free operation with this model’s heated lid and Thermal Isolation Frame. The graphical user interface of this Perkin Elmer model enhances user experience and provides clear instructions for hassle-free programming and manipulation.

Exchangeable sample blocks fitted into the system allow for convenient expansion of 0.5 mL to 0.2 mL in 96-well format. These supplementary instruments boost unit flexibility. Users have an option to choose between block and 0.5mL operating modes. Sample block temperature can be displayed on block mode. This capability is inherited from previous models including the DNA Thermal Cycler and DNA Thermal Cycler 480.

Learn more at Perkin Elmer

Upcoming Event

  • Reaction before action: new approaches to biomineralization-associated diseases

    12:30-13:30
    10/19/2017
    Daniel Laser, PhD CEO and Co-Founder, Applaud Medical RSVP Applaud Medical is a three-year-old company developing treatments for biomineralization-related diseases. Applaud's products use violent physical effects like cavitation and shock waves to achieve a therapeutic effect, while sparing non-targeted tissue through precise chemical targeting. Applaud's lead product, for low-invasiveness treatment of kidney stones, is currently in clinical trials in Gujarat, India. This seminar will cover technical aspects of combining chemical reactions with mechanical action in both Applaud's products and in a range of other drugs and devices, along with a brief discussion of key commercialization considerations for this uniquely promising product category. About Daniel Laser Daniel Laser is Chief Executive Officer and co-founder of Applaud Medical. Dan also founded Wave 80 Biosciences, a pioneer in detecting HIV during the high-transmission-risk earliest phase of infection, when the immune response is insufficiently advanced for antibody-based methods. He has served as board member or advisor to drug and device companies in fields ranging from autoimmune disease to ophthalmology to cancer. Dan got his start in the medical device field working on haptic feedback for telerobotic surgery systems. Dan holds a Ph.D. in mechanical engineering from Stanford University, where he was a Semiconductor Research Corporation Graduate Fellow. While at Stanford, he was also a MacArthur Affiliate at Stanford’s Center for International Security and Cooperation, developing mathematical models for protecting against threats involving weaponized pathogens.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter